GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » MedAssets Inc (NAS:MDAS) » Definitions » Probability of Financial Distress (%)

MedAssets (MedAssets) Probability of Financial Distress (%) : 0.00% (As of May. 05, 2024)


View and export this data going back to . Start your Free Trial

What is MedAssets Probability of Financial Distress (%)?

Probability of Financial Distress (%) measures the probability that a company will go bankrupt in the upcoming year given its current financial position. A higher ratio indicates a larger probability of bankruptcy for the company, while a lower ratio indicates a healthier fundamental. As of today, MedAssets's Probability of Financial Distress (%) is 0.00%.

Like the Altman Z-Score, the PFD measures a company's bankruptcy risk. However, the main drawback of the Z-score is it does not apply to banks and insurance companies. According to Investopedia, the concept of "working capital" does not apply to banks and insurance companies, as financial institutions do not have typical current assets or current liabilities like inventories or accounts payable.


Competitive Comparison of MedAssets's Probability of Financial Distress (%)

For the Health Information Services subindustry, MedAssets's Probability of Financial Distress (%), along with its competitors' market caps and Probability of Financial Distress (%) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MedAssets's Probability of Financial Distress (%) Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, MedAssets's Probability of Financial Distress (%) distribution charts can be found below:

* The bar in red indicates where MedAssets's Probability of Financial Distress (%) falls into.



MedAssets Probability of Financial Distress (%) Calculation

Probability of Financial Distress (%) (PFD) was developed by John Campbell, Jens Hilscher and Jan Szilagyi in their Search of Distress Risk. It measures the probability that a company will go bankrupt within the next 12 months given its current financial position.

The Probability of Financial Distress (%) was obtained by a logit probability model based on eight explanatory variables. The logit formula to compute the probability of financial distress (LPFD) is given below:

LPFD= -20.12 * NIMTAAVG + 1.60 * TLMTA - 7.88 * EXRETAVG + 1.55 * SIGMA - 0.005 * RSIZE - 2.27 * CASHMTA + 0.070 * MB - 0.09 * PRICE -8.87
=0.00

The Probability of Financial Distress (%) (PFD) was then obtianed by:

PFD=1/(1 + e^(-LPFD))*100%
=0.00%

The eight explanatory variables are:

1. NIMTAAVG = Net Income to Market Total Assets

NIMTAAVG=Net Income / Market Total Assets
=Net Income / (Market Cap + Total Liabilities)

*Note that for companies reported quarterly, geometrically declining weighted quarterly Net Income data in latest four quarters are used.

2. TLMTA = Total liabilities to Market Total Assets

TLMTA=Total Liabilities / Market Total Assets

3. CASHMTA = Cash to Market Total Assets

For non-financial companies, CASHMTA is measured as:

CASHMTA=Cash, Cash Equivalents, Marketable Securities / Market Total Assets

4. EXRETAVG = Excess Return compared to the S&P 500

EXRETAVG is the weighted excess return compared to the S&P 500 in past 12 month. Geometrically declining weights are imposed on the monthly excess return to reflect lagged information. The weight is halved each quarter.

5. SIGMA = Standard Deviation of Daily Returns

For sigma, we use the annualized standard deviation of a company's returns over the past 92 days (or 63 trading days).

6. RSIZE = Relative Size

RSIZE=log (Market Cap / Total Market Cap of S&P 500 companies)

7. MB = Market to Adjusted Book Equity Ratio


8. PRICE

PRICE is measured as the log of the stock price, capped at log(15).


MedAssets  (NAS:MDAS) Probability of Financial Distress (%) Explanation

Like the Altman Z-Score, the PFD measures a company's bankruptcy risk in the upcoming year. However, the main drawback of the Z-score is it does not apply to banks and insurance companies. According to Investopedia, the concept of "working capital" does not apply to banks and insurance companies, as financial institutions do not have typical current assets or current liabilities like inventories or accounts payable.


MedAssets Probability of Financial Distress (%) Related Terms

Thank you for viewing the detailed overview of MedAssets's Probability of Financial Distress (%) provided by GuruFocus.com. Please click on the following links to see related term pages.


MedAssets (MedAssets) Business Description

Traded in Other Exchanges
N/A
Address
MedAssets Inc was incorporated in 1999. It is a financial and performance improvement company providing technology-enabled products and services that, together, help mitigate the increasing financial challenges faced by hospitals, health systems, and other non-acute healthcare providers. Its solutions are designed to reduce the total cost of care delivery, enhance operational efficiency, align clinical delivery of physicians and staff to advance care coordination, and improve revenue performance mainly for hospitals and health systems. The Company's solutions integrate with its clients' existing operations and enterprise software systems, and require minimal upfront costs or capital expenditures for its clients. Its technology-enabled solutions are delivered through company-hosted software, sometimes referred to as software as a service or Web-based applications, supported by implementation, process improvement consulting and outsourced services, as well as enterprise-wide sales and client management support. The Company manages its business through two business segments, Spend and Clinical Resource Management (CM) and Revenue Cycle Management (RCM). Within the SCM segment it provides a comprehensive suite of cost management services, supply chain analytics and data capabilities that help its clients reduce their total cost of care delivery, enhance their operational efficiency and align their clinicians' delivery of care with advance care coordination. Its solutions lower operating costs through compliance to its strategic sourcing of supplies and purchased services at discounted prices, supply chain outsourcing and procurement services capabilities. It also help to improve care processes and reduce care variations through the use of its clinical and process improvement consulting services, workforce optimization solutions and business analytics and intelligence tools. The Company's RCM segment is a provider of revenue cycle management solutions to healthcare providers, mainly hospitals and health systems. It provides SaaS or Web-based software and technology-enabled services designed to improve revenue performance for healthcare organizations through patient access and financial responsibility, clinical documentation, charge capture and revenue integrity, pricing analysis, claims processing and denials management, payor contract management, extended business office revenue recovery, accounts receivable services and outsourcing. As of December 31, 2013, the Company's client base included more than 4,400 acute care hospitals and approximately 122,000 ancillary or non-acute provider locations. The Company competes with Allscripts Corporation, Epic Systems Corporation, McKesson Corporation, Siemens AG; Accenture Ltd., Accretive Health, Inc., Deloitte & Touche LLP, Ernst & Young LLP, Craneware Inc., Emdeon Inc. and among others. The Company is subject to federal and state laws and regulations designed to protect patients, government
Executives
Anthony Jr Colaluca officer: Chief Financial Officer MULTIPLAN CORPORATION, 115 FIFTH AVENUE, NEW YORK NY 10003
Bharat Sundaram officer: President, SCM Segment 100 NORTH POINT CENTER EAST, SUITE 200, ALPHARETTA GA 30022
C A Piccolo director 199 BENSON RD, MIDDLEBURY CT 06749
Carol J Zierhoffer director 100 NORTH POINT CENTER EAST, SUITE 200, ALPHARETTA GA 30022
Kevin M Twomey director 1650 PRUDENTIAL DR, STE 400, JACKSONVILLE FL 32207
Bruce F Wesson director 1827 PACIFIC ST BROOKLYN NY 11233
R Halsey Wise director, officer: Chairman and CEO 135 PONTE VEDRA BLVD, PONTE VEDRA BEACH FL 32082
Samuel K Skinner director 233 NORTH MICHIGAN AVENUE, 22ND FLOOR, CHICAGO IL 60601
Loucks Vernon R Jr director 1101 SKOKIE BLVD., SUITE 240, NORTHBROOK IL 60062
Laurence Neil Hunn officer: President, Revenue Cycle Tech 100 NORTH POINT CENTER EAST, SUITE 200, ALPHARETTA GA 30022
Patrick T Ryan director, officer: President, SCM Segment 401 EDGEWATER PLACE, SUITE 500, WAKEFIELD MA 01880
Claudius Llc 10 percent owner C/O GALEN ASSOCIATES 610 FIFTH AVENUE 5TH FLOOR NEW YORK NY 10020
Galen Partners Iii L P 10 percent owner 610 FIFTH AVE 5TH FL NEW YORK NY 10020
Galen Partners International Iii L P 10 percent owner 610 FIFTH AVENUE 5TH FLOOR NEW YORK NY 10020
Galen Employee Fund Iii Lp 10 percent owner 610 FIFTH AVENUE 5TH FLOOR NEW YORK NY 10020

MedAssets (MedAssets) Headlines

From GuruFocus

MEDASSETS, INC. (MDAS) CFO Laurence Neil Hunn sells 3,100 Shares

By GuruFocus Research GuruFocus Editor 06-03-2010

MEDASSETS, INC. (MDAS) Chairman, President and CEO John A Bardis sells 2,800 Shares

By GuruFocus Research GuruFocus Editor 03-01-2010

MEDASSETS, INC. (MDAS) Chairman, President and CEO John A Bardis sells 40,000 Shares

By GuruFocus Research GuruFocus Editor 12-01-2010

MEDASSETS, INC. (MDAS) Chairman, President and CEO John A Bardis sells 54,000 Shares

By GuruFocus Research GuruFocus Editor 03-01-2010

MEDASSETS, INC. (MDAS) COO Rand A Ballard sells 15,000 Shares

By GuruFocus Research GuruFocus Editor 02-09-2011

MEDASSETS, INC. (MDAS) COO Rand A Ballard sells 15,000 Shares

By GuruFocus Research GuruFocus Editor 12-08-2010

MEDASSETS, INC. Reports Operating Results (10-K)

By gurufocus 10qk 03-01-2011

MEDASSETS, INC. (MDAS) Chairman, President and CEO John A Bardis sells 26,776 Shares

By GuruFocus Research GuruFocus Editor 03-01-2010

MEDASSETS, INC. (MDAS) COO Rand A Ballard sells 6,000 Shares

By GuruFocus Research GuruFocus Editor 05-07-2010

MEDASSETS, INC. (MDAS) Chairman, President and CEO John A Bardis sells 40,000 Shares

By GuruFocus Research GuruFocus Editor 06-03-2010